Change search
ReferencesLink to record
Permanent link

Direct link
Ten years with biologics: to whom do data on effectiveness and safety apply?
Show others and affiliations
2011 (English)In: Rhematology Int, ISSN 1462-0324, E-ISSN 1462-0332, Vol. 50, no 1, 204-213 p.Article in journal (Refereed) Published
Abstract [en]

The trends in baseline characteristics and drug retention underscores that any effects of biologics, including comparison between different biologics, must be interpreted in light of the characteristics of the population treated. The observed differences further call for continued vigilance to properly evaluate the safety profiles of biologic treatments as they are currently used. Exposure to multiple biologics presents a challenge for attribution of long-term effects.

Place, publisher, year, edition, pages
2011. Vol. 50, no 1, 204-213 p.
Keyword [en]
Biologics, Rheumatoid arthritis, Anti-tumour necrosis factor, Psoriatic arthritis, Spondylarthritides
URN: urn:nbn:se:umu:diva-45881DOI: 10.1093/rheumatology/keq326PubMedID: 21084326OAI: diva2:435637
Available from: 2011-08-19 Created: 2011-08-19 Last updated: 2011-08-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Rantapää-Dahlqvist, Solbritt
By organisation
In the same journal
Rhematology Int

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 26 hits
ReferencesLink to record
Permanent link

Direct link